| ID: | 212 | |
|---|---|---|
| Name: | Compound 212 | |
| Description: | Original numeration in publication: 10h | |
| Labels: | Training_set, Quinazolines | |
| CAS: | ||
| InChi Code: | InChI=1S/C25H22N8O/c1-32(2)20-13-7-17(8-14-20)15-26-31-24(34)18-9-11-19(12-10-18)28-25-29-22-6-4-3-5-21(22)23-30-27-16-33(23)25/h3-16H,1-2H3,(H,28,29)(H,31,34)/b26-15+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 7.21 |
Abdallah, A. E.; Eissa, S. I.; Al Ward, M. M. S.; Mabrouk, R. R.; Mehany, A. B. M. a. E.-Z., M. A. Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation. Bioorg. Chem. 2021, 109, 104695. https://doi.org/10.1016/j.bioorg.2021.104695 |
| 7.01899 |
Eq1: VEGFR-2 inhibition (Data used to train model) |